A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Evaluations of echogenicity in gluteal muscle in patients with schizophrenia treated with second generation long-acting injectable antipsychotics: risperidone or aripiprazole
安原 由子 1 谷岡 哲也 1 高瀬 憲作 2 三木 理恵子 3 坂本 朋香 4 小澤 和弘 5 元木 一志 6 趙 岳人 7 阿瀬川 孝治 8 1 1 2 3 4 5 6 7 8 Second generation long-acting injectable antipsychotics (SG-LAIs) injected muscle region show high-echogenicity with acoustic shadowing on B-mode scan. This study aimed to distinguish two specific types of SG-LAIs at the gluteal muscle. Forty-seven patients [risperidone (RLAI): 28 patients, aripiprazole (ALAI): 19 patients] were examined using grayscale histogram analysis of echo-intensities. Pre-anddoi:10.2301/neurosonology.31.7 fatcat:txfl3zep35bclgahk6m2xp7btu